Mounjaro 7.5mg/dose Pre-filled 1 Pen (4 Doses)
Mounjaro 7.5 mg once-weekly pre-filled pen for blood sugar control
KD 103.000
brand :
Mounjaro
model_no : 127818 | 0
Mounjaro 7.5mg/dose Pre-filled 1 Pen (4 Doses)
Mounjaro QuickPen 7.5 mg/0.6 mL Once-weekly subcutaneous pen used with diet and exercise to help control blood sugar in adults with type 2 diabetes.
Benefits of Mounjaro 7.5mg/dose Pre-filled 1 Pen:
- Helps improve fasting and post-meal glucose as part of a comprehensive treatment plan.
- Aids post-prandial hormonal regulation and may support a feeling of fullness.
Features of Mounjaro 7.5mg/dose Pre-filled 1 Pen:
- Once weekly on a fixed day, with or without food.
- Single-dose, ready-to-use pen (no mixing) with simple, clear steps.
- The 7.5 mg strength serves as an early titration step to balance efficacy and tolerability before moving up.
Additional Information:
- Not for type 1 diabetes or treatment of DKA, and not a substitute for insulin.
- Stop and consult a doctor if you develop severe, persistent abdominal pain (possible pancreatitis).
- Temporary GI symptoms (nausea/vomiting/diarrhoea) can occur—keep well hydrated.
- Risk of hypoglycaemia may increase with sulfonylureas/insulin.
- Delays gastric emptying; oral contraceptives may require additional protection temporarily.
- Not indicated for <18 years.
Storage method:
Store refrigerated at 2–8 °C, protected from light; may be kept at ≤30 °C for up to 21 days.
made in:
Italy
- Tirzepatide 7.5 mg/0.6 mL
- Inject subcutaneously once weekly in the abdomen, thigh, or upper arm, rotating the injection site each week.
- Missed dose: Take it within 96 hours of the scheduled time; if more than 96 hours have passed, skip the missed dose and take the next one at your usual time.
- You may change the injection day provided there are ≥72 hours between two doses.
- Do not mix with insulin in the same injection; they may be given in the same area but not at the same site.
- Disposal: Discard used pens in an approved sharps container.
